FDA Revamps Medical Device Approval - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IoT
IoT
Healthcare // Analytics
News
1/20/2011
02:42 PM
50%
50%

FDA Revamps Medical Device Approval

The 510(k) program overhaul aims to facilitate innovation, streamline the review process, and protect patient safety.

Health IT Boosts Patient Care, Safety
(click image for larger view)
Slideshow: Health IT Boosts Patient Care, Safety

The Food and Drug Administration unveiled Wednesday a plan to revamp its 510(k) program that medical device manufacturers use to clear their products before they can be marketed and sold to the public.

Many medical device manufacturers see the efficient running of the 510(k) program as pivotal to stimulating U.S. innovation, investment, and job growth in the medical device industry. The FDA's Center for Devices and Radiological Health (CDRH) uses the program to clear some 3,000 new medical devices for patients each year.

"Facilitating innovation is a critical part of the agency's responsibility to promote the public health, but this can happen only if the U.S. can support a robust, innovative, medical device industry," Jeffrey Shuren, director of FDA's center for devices and radiological health, said in a statement. "The steps we are announcing today remove roadblocks to innovation while protecting patient safety."

To facilitate innovation in medical devices, the FDA will:

-- Streamline the review process for innovative, lower-risk products, called the "de novo" process;

-- Publish guidance for industry to clarify when clinical data should be submitted to increase predictability and transparency;

-- Develop a network of external experts who can use their knowledge and experience to help the agency address important scientific issues regarding new medical device technologies; and

-- Establish a new Center Science Council of senior FDA experts within the agency's medical device center to assure more timely and consistent science-based decision making.

The FDA also announced that it will strengthen its capacity to examine and monitor the safety of medical devices once they are on the market and being used. It will establish a public database of important device information, such as medical device labeling and summaries of the basis for the FDA's decision to clear specific devices. It will also require a brief description of scientific information regarding the safety and effectiveness known to the manufacturer for select higher-risk devices on a case-by-case basis through device-specific guidance.

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
Previous
1 of 2
Next
Comment  | 
Print  | 
More Insights
Commentary
2021 Outlook: Tackling Cloud Transformation Choices
Joao-Pierre S. Ruth, Senior Writer,  1/4/2021
News
Enterprise IT Leaders Face Two Paths to AI
Jessica Davis, Senior Editor, Enterprise Apps,  12/23/2020
Slideshows
10 IT Trends to Watch for in 2021
Cynthia Harvey, Freelance Journalist, InformationWeek,  12/22/2020
White Papers
Register for InformationWeek Newsletters
Video
Current Issue
2021 Top Enterprise IT Trends
We've identified the key trends that are poised to impact the IT landscape in 2021. Find out why they're important and how they will affect you.
Slideshows
Flash Poll